Sign inCreate account

Report workspace tools

NCT01839084COMPLETEDanonymous

Impact of Xenon-anesthesia on the Renal Function After Partial Nephrectomy - PaNeX: Partial Nephrectomy Under Xenon:a Pilot Study

Sponsor

Source record

RWTH Aachen University

Phase

Source record

PHASE3

Modality

AI-normalized

gene therapy

Target

AI-normalized

Xenon, Isoflurane

Indication / condition

AI-normalized

Renal Function After Partial Nephrectomy

Intervention

Source record

Xenon, Isoflurane

Source & freshness

Source record

NCT ID

NCT01839084

Original source

ClinicalTrials.gov

Source last updated

Feb 18, 2016

Ingested at

May 22, 2026

Internal sync

May 23, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT01839084

Title

Impact of Xenon-anesthesia on the Renal Function After Partial Nephrectomy - PaNeX: Partial Nephrectomy Under Xenon:a Pilot Study

Sponsor

RWTH Aachen University

Status

COMPLETED

Phase

PHASE3

Condition raw

Renal Function After Partial Nephrectomy

Condition normalized

Renal Function After Partial Nephrectomy

Modality raw

gene therapy

Modality normalized

gene therapy

Target raw

Xenon, Isoflurane

Target normalized

Xenon, Isoflurane

Interventions

Xenon, Isoflurane

Public preview

Source record

Purpose of this study is to determine whether Xenon - as compared to Isoflurane - shows a nephroprotection after partial nephrectomy.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Impact of Xenon-anesthesia on the Renal Function After Partial Nephrectomy - PaNeX: Partial Nephrectomy Under Xenon:a Pilot Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01839084

Status

COMPLETED

Phase

PHASE3

Sponsor

RWTH Aachen University

Executive brief

Investment-Ready Snapshot

Purpose of this study is to determine whether Xenon - as compared to Isoflurane - shows a nephroprotection after partial nephrectomy.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 18, 2016
Internal syncMay 23, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01839084

Indication

Renal Function After Partial Nephrectomy

Modality

gene therapy

Target

Xenon, Isoflurane

Intervention

Xenon, Isoflurane

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.